Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05696470 · ClinicalTrials.gov registry record
Fusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs
A clinical trial of Radiculopathy and Myelopathy Cervical, sponsored by Ohio State University.
- Active
- Registry status
- 58
- Enrollment target
- 1
- Study location
NCT05696470: Active study of Radiculopathy and Myelopathy Cervical, sponsored by Ohio State University.
NCT05696470 is a study of Radiculopathy and Myelopathy Cervical that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 58 participants, above the 51-participant average among 3 other Radiculopathy trials with a reported enrollment target (14% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05696470, a study of Radiculopathy and Myelopathy Cervical, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to assess fusion rates in 3 and 4 level ACDFs in patients implanted with DePuy Conduit 3D printed titanium cages supplemented with SKYLINE Anterior Cervical Plate System and 1 CC DBM. This will be a non-inferiority study, looking to show that Synthes Conduit 3D printed titanium cages fuse as well as cages.
Primary Outcome
based on postoperative X-ray: presence of bone trabeculae across graft-host interface, absence of radiolucent gap between graft and adjacent vertebral body, restriction of motion to 2mm or less between adjacent vertebral spinous processes on flexion-extension lateral radiographs
Conditions Studied
Interventions
- DEVICE DePuy Synthes Conduit 3D printed titanium cages
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center Neurological Surgery - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2021-03-31 |
| Est. Completion | 2026-12-31 |
What the registry record for NCT05696470 still lists
NCT05696470 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target, above the 51-participant average among 3 other Radiculopathy trials with a reported enrollment target (14% higher).
The record links to 4 conditions, with Radiculopathy appearing as the primary indexed condition, and to 1 intervention - of which DePuy Synthes Conduit 3D printed titanium cages is the first listed.
NCT05696470 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05696470 about?
NCT05696470 is a clinical study titled "Fusion Rates of 3D Printed Porous Titanium Cages in Three and Four Level ACDFs". The purpose of this trial is to assess fusion rates in 3 and 4 level ACDFs in patients implanted with DePuy Conduit 3D printed titanium cages supplemented with SKYLINE Anterior Cervical Plate System and 1 CC DBM. This will be a non-inferiority study, looking to show that Synthes Conduit 3D printed t...
What is the current status of trial NCT05696470?
This trial is currently active not recruiting. The enrollment target is 58 participants. The study started on 2021-03-31. Estimated completion is 2026-12-31.
What conditions does trial NCT05696470 study?
This clinical trial studies the following conditions: Radiculopathy, Myelopathy Cervical, Foraminal Stenosis, Central Canal Stenosis.
What interventions are being tested in trial NCT05696470?
The interventions under investigation include: DePuy Synthes Conduit 3D printed titanium cages (DEVICE).
Who is sponsoring clinical trial NCT05696470?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05696470 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiculopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI